Abstract Diallyl trisulfide (DATS) is a structurally simple but biologically active constituent of processed garlic with in vivo activity against chemically induced as well as oncogene-driven cancer in experimental rodents. This study offers novel insights into the mechanisms underlying anticancer effects of DATS using human breast cancer cells as a model. Exposure of human breast cancer cells (MCF-7 and MDA-MB-231) and a cell line derived from spontaneously developing mammary tumor of a transgenic mouse (BRI-JM04) to DATS resulted in a dose-dependent inhibition of cell viability that was accompanied by apoptosis induction. A non-tumorigenic normal human mammary cell line (MCF-10A) was resistant to growth inhibition and apoptosis induction by DATS. The DATS-induced apoptosis in MDA-MB-231, MCF-7, and BRI-JM04 cells was associated with reactive oxygen species (ROS) production as evidenced by fluorescence microscopy and flow cytometry using a chemical probe (MitoSOX Red). Overexpression of Cu,Znsuperoxide dismutase (Cu,Zn-SOD) as well as Mn-SOD conferred significant protection against DATS-induced ROS production and apoptotic cell death in MDA-MB-231 and MCF-7 cells. Activation of Bak, but not Bax, resulting from DATS treatment was markedly suppressed by overexpression of Mn-SOD. The DATS treatment caused ROS generation, but not activation of Bax or Bak, in MCF-10A cells. Furthermore, the DATS-mediated inhibition of cell migration was partially but significantly attenuated by Cu,Zn-SOD and Mn-SOD overexpression in association with changes in levels of proteins involved in epithelial-mesenchymal transition. The DATS-mediated induction of heme oxygenase-1 was partially attenuated by overexpression of Mn-SOD. These results provide novel mechanistic insights indicating a critical role for ROS in anticancer effects of DATS.
Introduction
Epidemiological studies have revealed an inverse association between dietary intake of Allium vegetables (e.g., garlic and onion) and cancer risk [1, 2] . Water-soluble as well as lipid-soluble organosulfur compounds (OSCs) with anticancer activity have now been identified from Allium vegetables [3, 4] . It has been shown that even a subtle change in the structure of lipid-soluble OSCs can profoundly affect their anticancer activity in vitro (e.g., inhibition of cancer cell proliferation and apoptosis induction) [5] . For example, diallyl trisulfide (DATS) is a much more potent inducer of apoptotic cell death compared with diallyl sulfide or diallyl disulfide in human prostate and breast cancer cells [5, 6] . Likewise, structure-activity relationship studies have established a critical role for the allyl group in anticancer effects of lipid-soluble OSCs as the compounds with saturated groups flanking the sulfur atoms (e.g., propyl groups) are inactive regardless of the number of sulfur atoms [5] .
Anticancer effect of lipid-soluble OSCs has been extended to in vivo models [6] [7] [8] [9] [10] [11] [12] . For example, we were the first to demonstrate that oral administration of diallyl disulfide inhibited growth of H-RAS oncogene transformed cells subcutaneously implanted in athymic mice in association with inhibition of p21-H-ras processing in the tumor [7] . Likewise, gavage with 6 lmol DATS three times per week to PC-3 human prostate cancer bearing male athymic mice resulted in retardation of the xenograft growth [9] . Tumor volume for MCF-7 human breast cancer xenografts was significantly lower compared with control after oral treatment with 5 lmol/kg DATS twice per week for 1 month in female Balb/c nude mice [6] . The incidence of poorly differentiated carcinoma in the dorsolateral prostate of mice treated with 2 mg DATS/mouse/day (three times per week) was lower by 41 % (P = 0.035) in comparison with control mice [11] . In addition, DATS treatment inhibited angiogenic features in human umbilical vein endothelial cells [13] .
The mechanisms underlying anticancer effects of DATS are not fully understood, but known cellular responses to this agent in cultured cancer cells include G 2 phase and mitotic arrest [14] [15] [16] and apoptosis induction [5, 6, 17, 18] . Previous studies, including those from our laboratory, have also revealed that the cell cycle arrest and apoptosis induction resulting from DATS exposure are associated with production of reactive oxygen species (ROS) [5, 6, 14, 17] . However, the mechanisms downstream of ROS production in DATS-induced apoptosis are not fully understood. This study provides novel insights into the mechanism by which ROS regulates anticancer effects of DATS.
Materials and methods
Reagents DATS (purity [98 %) was purchased from LKT Laboratories (St. Paul, MN). Cell culture reagents were purchased from Invitrogen-Life Technologies (Grand Island, NY); 4 0 ,6-diamidino-2-phenylindole (DAPI), eosin, and antiactin antibody were obtained from Sigma-Aldrich (St. Louis, MO); antibodies against total and active Bak, Mn-superoxide dismutase (Mn-SOD), and Cu,Zn-SOD were from Calbiochem-EMD Millipore (Billerica, MA); the antibody against active Bax (clone 6A7) and E-cadherin were purchased from BD Transduction Laboratories-BD Biosciences (San Jose, CA). An antibody against vimentin and heme oxygenase-1 were procured from Santa Cruz Biotechnology (Santa Cruz, CA). A kit to quantify histone-associated DNA fragment release into the cytosol was from Roche Diagnostics (Indianapolis, IN).
Cell lines
The MCF-7, MDA-MB-231, and MCF-10A cells were obtained from the American Type Culture Collection (Manassas, VA) and cultured as described by us previously [19] . The BRI-JM04 cell line (a generous gift from Dr. Anne Lenferink, Biotechnology Research Institute, Montreal, Canada) was maintained in Dulbecco's modified essential medium supplemented with 10 % fetal bovine serum, 2 mM L-glutamine, and antibiotics. Each of these cell lines was authenticated and found to be of human (MCF-7, MDA-MB-231, and MCF-10A) or mouse (BRI-JM04) origin.
Cell viability and apoptosis assays
Stock solution of DATS was prepared in dimethyl sulfoxide (DMSO) and diluted with complete medium before experimental procedure. An equal volume of DMSO (final concentration \0.2 %) was added to controls. Desired cell line was treated for 24 h with either DMSO (control) or specified concentrations of DATS. The effect of DATS treatment on cell viability was determined by trypan blue dye exclusion assay as described by us previously [5] . Apoptosis induction resulting from DATS treatment (24 h exposure) was assessed by analysis of histone-associated DNA fragment release into the cytosol.
Measurement of ROS production ROS generation was determined by fluorescence microscopy or by flow cytometry using a chemical probe (MitoSOX Red) as described previously [20] .
Stable overexpression of Mn-SOD and Cu,Zn-SOD MCF-7 and MDA-MB-231 cells were stably transfected with pcDNA3.1 empty vector or the same vector encoding for Mn-SOD or Cu,Zn-SOD using Fugene6. Cells were selected by culture in the presence of 800 lg/mL of G418. Overexpression of the desired protein was confirmed by western blotting.
Immunocytochemical analysis
Desired cells (4 9 10 4 cells/mL) were cultured on coverslips and allowed to attach by overnight incubation. The cells were treated with DMSO or DATS for specified time at 37°C. Immunocytochemical analysis for active Bax or active Bak was performed as described previously [20] . The stained cells were examined under a Leica DC300F microscope at 1009 objective magnification.
Cell migration assay
Cell migration was determined using Transwell Boyden chamber (Corning, NY) containing a polycarbonate filter with a pore size of 8 lm as described previously [21] . The motile cells on the bottom face of the membrane were fixed with 90 % ethanol and stained with eosin. Four randomly selected fields were examined under a microscope at 109 objective magnification.
Immunoblotting
Details of cell lysate preparation and western blotting have been described by us previously [22, 23] . The immunoreactive bands were detected using enhanced chemiluminescence method. The blots were stripped and reprobed with anti-actin antibody to normalize for differences in protein loading.
Statistical analysis
Statistical significance of difference in measured variables between control and DATS-treated groups was determined by one-way ANOVA followed by either Dunnett's test (for dose-response studies) or Bonferroni's test (for multiple comparisons). Difference was considered significant at P \ 0.05.
Results

DATS-inhibited viability of breast cancer cells in association with apoptosis induction
During the preparation of this manuscript, Na et al. [6] showed inhibition of MCF-7 cell viability in the presence of DATS. Because MCF-7 cell line is estrogen-sensitive and expresses wild-type p53, it was of interest to determine if DATS-mediated inhibition of cell viability was affected by estrogen-receptor, p53, or human epidermal growth factor receptor-2 (HER-2) status. We addressed this question using MDA-MB-231 cells (estrogen-independent cell line with mutant p53 and normal HER-2) and BRI-JM04 (estrogenreceptor negative mouse mammary tumor cell line with HER-2 overexpression). As shown in Fig. 1a , viability of MDA-MB-231, MCF-7, and BRI-JM04 cells was inhibited in the presence of DATS in a concentration-dependent manner. Moreover, each tested cell line exhibited more or less similar sensitivity to DATS (Fig. 1a) . Interestingly, the viability of MCF-10A cell line (a non-tumorigenic cell line originally isolated from a fibrocystic breast disease and spontaneously immortalized) was not affected in the presence of DATS (Fig. 1a) . Consistent with previous observations in MCF-7 cells [6] , the DATS-mediated inhibition of MDA-MB-231 and BRI-JM04 cell viability was accompanied by apoptosis induction as judged by analysis of histoneassociated DNA fragment release into the cytosol (Fig. 1b) . Similar to cell viability data, the MCF-10A cell line was resistant to DATS-induced apoptosis (Fig. 1b) .
DATS treatment caused ROS generation in cancerous and normal breast cells ROS have been implicated in apoptosis induction by several cancer chemopreventive phytochemicals, including withaferin A and isothiocyanates [19, 20, 24, 25] . Moreover, the DATS-induced apoptosis in MCF-7 cells was associated with ROS production [6] . We questioned if the ROS dependence of DATS-induced apoptosis was unique to the MCF-7 cell line. This study indicated that the ROS production upon exposure to DATS was a generalized phenomenon as evidenced by the data in MDA-MB-231 and BRI-JM04 cells using a chemical probe of ROS detection (MitoSOX Red). The MitoSOX Red is a cell permeable and mitochondria-targeting chemical probe. As shown in Fig. 2a , MitoSOX Red fluorescence in the DMSO-treated control MDA-MB-231 and MCF-7 cells was weak and diffuse. On the other hand, treatment of both MDA-MB-231 and MCF-7 cells with DATS (3 h) resulted in enrichment of MitoSOX Red fluorescence that co-localized with the mitochondria as evidenced by appearance of yellow-orange color due to the merging of MitoSOX Red-associated red fluorescence and MitoTracker green-associated green fluorescence (Fig. 2a) . The basal MitoSOX Red fluorescence was relatively higher in the non-tumorigenic MCF-10A cell line than in either MDA-MB-231 or MCF-7. However, similar to breast cancer cells, DATS treatment caused an increase in MitoSOX Red fluorescence in MCF-10A cells as well (Fig. 2a) . The DATS-mediated ROS production in MDA-MB-231, MCF-7, BRI-JM04, and MCF-10A cells was confirmed by flow cytometry (Fig. 2b) . However, cell line-specific differences in the kinetics of DATS-induced ROS production were also observed. For example, ROS generation by DATS treatment was sustainable for up to 6 h in MDA-MB-231 and BRI-JM04 cells. On the other hand, enrichment of MitoSOX Red fluorescence over DMSO-treated control peaked between 3 and 6 h in MCF-7 cells (Fig. 2b) . The DATS-mediated ROS production was modest but highly variable or statistically insignificant at the 1-or 2-h time points at least in MCF-7 cells (results not shown).
Overexpression of SOD conferred protection against DATS-induced apoptosis
Previous studies have utilized small molecule antioxidant N-acetylcysteine to determine the role for ROS in DATSinduced apoptosis [6] . In this study, we used a genetic approach involving overexpression of SOD to firmly establish the contribution of ROS in apoptotic cell death by DATS. A genetic method is preferred over a chemical approach involving small molecules due to the possibility of off-target effects. As expected, overexpression of both Cu,Zn-SOD and Mn-SOD (Fig. 3a) resulted in a significant decrease in DATS-mediated ROS production in MDA-MB-231 and MCF-7 cells (Fig. 3b) . Inhibition of cell viability (Fig. 3c) as well as apoptosis induction (Fig. 3d) resulting from DATS exposure (24 h treatment) was partially but statistically significantly attenuated by overexpression of SOD (both Cu,Zn-SOD and Mn-SOD) in MDA-MB-231 and MCF-7 cells. Notably, the extent of DATS-induced apoptosis in vector transfected control Results shown are mean ± SD (n = 3). *Significantly different (P \ 0.05) compared with DMSO-treated control by oneway ANOVA followed by Dunnett's test. Each experiment was performed at least twice MDA-MB-231 cells (Fig. 3) was different from that observed in the un-transfected cells (Fig. 1) . The discrepancy likely results from variability inherent to the assay for histone-associated DNA fragment release into the cytosol and/or cellular alterations associated with transfection.
Overexpression of SOD attenuated DATS-mediated activation of Bak in breast cancer cells
The results shown thus far indicated that ROS generation was critical for apoptosis induction by DATS but did not offer any insight into the mechanisms downstream of ROS generation in apoptotic cell death. The ROS-dependent activation of Bax and/or Bak is one possible mechanism underlying DATS-induced apoptosis. The ROS-dependent activation of Bax and/or Bak has been demonstrated previously in some models of apoptosis [26, 27] . We therefore determined the effect of DATS treatment on activation of Bax and Bak by immunofluorescence microscopy using antibodies specific for detection of activated proteins. As shown in Fig. 4a,b , the DATS treatment resulted in an increase in fluorescence associated with the active Bax and Bak in empty vector (Fig. 4a) . In contrast, Mn-SOD overexpression protected against DATS-mediated activation of Bak (Fig. 4b) . These results indicated that overexpression of Mn-SOD attenuated DATS-mediated activation of Bak, but not Bax, in MCF-7 cells. Unlike MCF-7 cells, DATS-mediated activation of Bax or Bak was not readily evident in the MCF-10A cell line (Fig. 4c) . These results explain resistance of MCF-10A cells to DATS-induced apoptosis despite ROS production.
SOD overexpression attenuated DATS-mediated inhibition of MDA-MB-231 cell migration
An important component of tumor progression is the propensity of cancer cells to migrate and invade [28] . As shown in Fig. 5a , DATS treatment inhibited migration of (Fig. 5b) . These results indicated that DATS-mediated inhibition of breast cancer cell migration was partially dependent on ROS production.
DATS treatment up-regulated E-cadherin in MDA-MB-231 breast cancer cells
The epithelial-mesenchymal transition (EMT) is critical for migration of cancer cells [29] . Suppression of E-cadherin coupled with induction of mesenchymal marker proteins (e.g., vimentin) is a biochemical hallmark of EMT [29] . We raised the question of whether DATS treatment inhibited EMT and whether this effect was related to ROS production. This analysis was restricted to MDA-MB-231 cells because MCF-7 is an epithelial-type cell line.
Immunoblotting experiments revealed modest induction of E-cadherin and suppression of vimentin in DATS-treated MDA-MB-231 cells (Fig. 6a) . The DATS-mediated induction of E-cadherin was confirmed by immunofluorescence microscopy using empty vector transfected MDA-MB-231 cells (Fig. 6b) . Interestingly, overexpression of Mn-SOD alone resulted in induction of E-cadherin, which is consistent with tumor suppressor role for Mn-SOD [30] [31] [32] . However, overexpression of Mn-SOD markedly attenuated DATS-mediated induction of E-cadherin (Fig. 6b) . The empty vector transfected MDA-MB-231 cells exhibited suppression of vimentin protein level after 24 h treatment with DATS. On the other hand, the DATSmediated suppression of vimentin protein expression was not observed in Mn-SOD overexpressing MDA-MB-231 cells. These results not only indicated redox-sensitive regulation of E-cadherin protein expression, but also suggested that the Mn-SOD-mediated protection against cell migration inhibition by DATS may, at least in part, be related to modulation of the EMT.
Mn-SOD overexpression partially protected DATSmediated induction of heme oxygenase-1 (HO-1)
Induction of detoxifying enzymes is believed to contribute to cancer chemoprevention by DATS [33] . We addressed the question of whether DATS-mediated ROS generation was responsible for induction of detoxifying enzymes. As shown in Fig. 6d , induction of a prototypical detoxification protein HO-1 was only partially attenuated by overexpression of SOD especially at the higher doses (Fig. 6d) .
Discussion
The DATS is a naturally occurring cancer chemopreventive agent that has been tested for its in vivo efficacy in rodent cancer models [6, [8] [9] [10] [11] [12] and in humans [34] . A double-blinded and placebo-controlled interventional study in China using 200 mg of synthetic DATS every day plus 100 lg of selenium indicated that DATS was well tolerated by all subjects [34] . In the first 5 years of follow-up after stopping the treatment, a decline in cancer morbidity rate was observed in the interventional group [34] . The relative risks, after adjustment for age, gender, and other confounders, for all tumors and gastric cancer were 0.67 (95 % confidence interval 0.43-1.03) and 0.48 (95 % confidence interval 0.21-1.06), respectively [34] . This study indicates, for the first time, that the DATS treatment causes apoptosis induction in breast cancer cells regardless of the estrogen-receptor, p53, and HER-2 status. Notably, inhibition of cell viability and migration and apoptosis induction resulting from DATS exposure in cultured breast cancer cells are observed at pharmacologically achievable concentration based on pharmacokinetic data in rats [35] . The mechanism by which DATS causes ROS production has been investigated previously and involves elevation of labile iron pool due to ferritin degradation in an c-jun NH 2 -terminal kinase-dependent manner [36] [37] [38] . A role for the adapter protein p66Shc in DATS-induced apoptosis was also demonstrated recently [37] . Another objective of this study was to firmly establish the role of ROS in anticancer effects of DATS because previous studies have mostly relied on small molecule antioxidants to establish this association [6, 14] . Results described herein indicate that ROS generation is critical not only for DATS-induced apoptosis but also inhibition of the cell migration. The ROS-dependent activation of Bak, but not Bax, seems critical for apoptosis induction by DATS, whereas redoxsensitive changes in EMT markers is associated with inhibition of cell migration. It is important to point out that, to the best of our knowledge, this study is the first to show modulation of EMT by DATS treatment. However, the mechanism by which DATS treatment inhibits biochemical features of EMT (i.e., induction of E-cadherin and vimentin suppression) remains elusive. Nevertheless, it is reasonable to conclude that ROS may not fully account for the induction of apoptosis as well as inhibition of cell migration by DATS as these effects are only partially attenuated by overexpression of SOD.
The relationship between DATS-mediated ROS production and activation of c-jun NH 2 -terminal kinases (JNK) has been studied in the MCF-7 cell line [6] . The DATS was shown to cause JNK activation in an ROS-dependent manner in MCF-7 cells [6] . These observations are consistent with our own data in prostate cancer cells [5] . Based on these results, we conclude that ROS function upstream of JNK activation in execution of DATS-induced apoptosis.
The possibility that DATS-mediated inhibition of breast cancer cell migration is partly due to ensuing apoptosis cannot be excluded because both these effects are partially abrogated by overexpression of SOD. Molecular circuitry facilitating cancer cell migration is quite complex involving alterations in cell morphology and activation of signaling mechanisms [39] . Literature data exists to suggest redox-sensitive regulation of cancer cell migration [40] . For example, members of the mitogen-activated protein kinase family are activated during cell migration, and ROS have been implicated in activation of these kinases via growth factor stimulation of receptor tyrosine kinases [41, 42] . Growth factor-stimulated ROS have been shown to transmit signals necessary for cell migration [39] . ROS can also serve to trigger cell death as is the case for DATS. It is possible that the level of oxidative stress after treatment of cancer cells with DATS is sufficient to provoke apoptosis and inhibition of cell migration as observed in this study.
The potential adverse effect of ROS production by DATS deserves attention as oxidative stress is linked to the pathogenesis of many chronic diseases including cancer. However, the DATS-mediated ROS production may simply serve to kill cancer cells without having any harmful side effects as evidenced by the following observations: (a) DATS is abundant in vegetables consumed by humans on a daily basis, yet epidemiological data indicate an inverse association between dietary intake of Allium vegetables and the risk of cancer [1, 2] ; (b) DATS administration is well tolerated by experimental animals as well as humans [6, [10] [11] [12] ; and (c) the DATS-mediated inhibition of cell viability and apoptosis induction is selective for cancer cells and not evident in a normal human mammary epithelial cell line.
